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Summary 
In the absence of a survival stimulus, the interleukin 3 (IL-3)-dependent IC.DP cell line undergoes 
a process termed programmed cell death or apoptosis.  Survival can be induced by IL-3, which 
can also stimulate proliferation of IC.DP cells. IC.DP cells have been stably transfected  with 
the p160  v-abl protein tyrosine kinase,  activation of the kinase at  the permissive  temperature 
permits cell survival in the absence of IL-3 by suppression of apoptosis, although the growth 
factor is still required for proliferation. Both IL-3 and activation of the v-ABL tyrosine kinase 
stimulated glucose transport, which may in part be due to a translocation of transporters to 
the cell surface. Inhibition of glucose uptake markedly increased the rate of apoptosis in these 
cells, an effect that could be reversed by the provision of alternative energy sources such as glutamine. 
Growth factor- or oncogene-mediated increases in glucose uptake may therefore represent an 
important regulatory point in the suppression of apoptosis. 
poptosis plays an essential role in development, both in 
morphogenesis and in processes such as lymphopoiesis 
(1, 2). In the hemopoietic system, withdrawal of hemopoietic 
growth factors, such as IL-3, from progenitor cells has been 
shown to induce apoptosis (3-5). However, the requirement 
for growth factors for suppression of apoptosis appears to 
be abrogated in some malignancies. For example, malignant 
cells from patients with follicular B cell lymphoma or non- 
Hodgkin's lymphoma exhibit an enhanced survival potential 
in the absence of hemopoietic growth factors (6), possibly 
resulting from overexpression of the bcl-2 gene (7, 8). Similar 
behavior is observed in progenitor cells from patients with 
chronic myeloid leukemia (9-11),  which is associated with 
an activated form of the Abelson protein tyrosine kinase (v- 
ABL) (12). Such changes in the ability of hemopoietic ceils 
to survive in adverse conditions may constitute one aspect 
of leukemogenesis. 
The pleiotropic effects of growth factors, which include 
promotion of progenitor cell proliferation and development, 
complicate the assessment of the molecular mechanisms of 
apoptotic suppression. For this reason we have studied such 
mechanisms using the IL-3-dependent IC.DP cell line, which 
was generated from the IC2.9 mast cell line (13) by transfec- 
tion with a mutant v-abt gene encoding a temperature-sensitive 
protein tyrosine kinase  (PTK) 1 (14). Withdrawal of IL-3 
1  Abbreviations used in this paper: CB, cytochalasin  B; DCB, dihydrocyto- 
chalasin B; 2-DOG, 2-deoxy-D-glucose;  PBST, PBS with Tween; PTK, 
protein tyrosine kinase. 
from IL-3-dependent cell lines induces a rapid decrease in 
metabolism of glucose (15, 16), which nuclear magnetic res- 
onance (NMR) analysis has indicated to occur primarily via 
anaerobic glycolysis (17). The uptake of glucose into the cell 
represents  a key point in the regulation of its metabolism, 
and is known to be stimulated by IL-3 and by other hemo- 
poietic growth factors (15, 16, 18-20). In view of the abro- 
gation of the survival requirement for IL-3 by activation of 
v-ABL, we assessed the effects of v-ABL activity on glucose 
uptake to determine the relationship, if any, between glucose 
transport  and  apoptotic suppression.  We  have previously 
shown that activation of v-ABL suppresses apoptosis and thus 
prolongs the survival, but does not allow the proliferation, 
of IC.DP cells in the absence of growth factor (21, 22). Here 
we demonstrate that v-ABL activation suppresses the onset 
of apoptosis in IC.DP cells via a stimulation of glucose uptake. 
Materials and Methods 
Cell Culture and Reagents.  IC.DP  cells were maintained in 
Fischer's medium supplemented with 10% (vol/vol) horse serum 
and 3%  (vol/vol) Ib3-containing X63-Ag-653 cell-conditioned 
medium as previously described (21, 22). 
Detection of Phosphorylation of the p160  ~*bl Tyrosine Kinase.  321)_ 
labeled cell lysates were immunoprecipitated with polyclonal  anti- 
bodies against c-ABL (Cambridge Bioscience, Cambridge, UK), 
followed  by SDS/polyacrylamide  gel electrophoresis  and autoradi- 
ography using previously described methods (21, 22). 
Detection of GLUT1 by Western Blotting.  SDS/polyacrylamide 
electrophoresis  and Western blotting were performed as described 
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with PBS containing 5% nonfat dry milk powder for >11 h at room 
temperature  and  then incubated with  PBS containing  1%  milk 
powder,  0.05%  (vol/vol) Tween 20,  and  1 #g/ml of rabbit anti- 
body against GLUT-1  (24)  for I>1 h  at room temperature.  After 
washing twice with  PBS containing 0.05%  (vol/vol) Tween  20 
(PBST) for 15 min, the membrane was incubated with PBST con- 
taining  1%  milk powder and a  1:10,000 dilution  of horseradish 
peroxidase-conjugated donkey antibody against rabbit IgG (Amer- 
sham International,  Bucks,  UK) for/>1 h  at  room temperature. 
After 2 washes  with PBST for 15 min, the blot was rinsed  with 
PBS and 0.125  ml/cm  2 of electrochemiluminescence (ECL) solu- 
tions mixture (Amersham International) was added.  The pattern 
of fluorescence  on  the  membrane  was  recorded  using  Kodak 
X-OMAT-AR film. 
2-Deoxy-n-Glucose  (2-DOG) Uptake  Assay.  Cells  were taken from 
mid log-phase cultures grown for 18 h at 39~  to ensure inactiva- 
tion of v-ABL (21, 22).  They were then washed three times  over 
a period of 2 h  at 39~  in Fischer's  medium containing 5 mM 
Hepes,  pH 7.4,  to remove IL-3. For 2-DOG uptake assays, cells 
were rapidly centrifuged and resuspended  in ice-cold PBS, pH 7.3. 
They were then kept on ice for <30 min before  assaying the up- 
take  of [3H]2-DOG  (Amersham  International).  Transport  was 
measured at 37~  with  1 mM 2-DOG, and an uptake period of 
1 min,  using the oil-stop assay previously described  (15). 
Confocal Immunofluorescence  Microscol~.  Cells were prepared for 
microscopy by centrifugation onto glass  slides using a Shandon 
cytospin II centrifuge for 3 rain at 200g. After air drying for >/1 h, 
the cells were fixed and permeabilized  with acetone for 3 min at 
room temperature.  Slides were stained  by incubation for 30 rain 
with affinity-purified rabbit antibody against the COOH terminus 
of GLUT1 (24) (10 #g/ml in PBS containing 10% FCS and 0.1% 
sodium azide) followed by FITC-conjugated goat anti-rabbit IgG 
(Pierce & Warriner,  Chester, UK). After mounting in 90% glycerol 
containing 25 mg/ml 1,4-diazobicyclo-(2,2,2)-octane  (25) (Sigma 
Chemical Co.,  Poole,  UK) slides were examined  using a micro- 
scope (Zeiss, Cambridge, UK) equipped with a laser (model MRC 
600; Bio-Rad Laboratories, Richmond, CA) scanning confocal unit. 
Assay for Apoptosis.  IC.DP cells were cultured at 39~  over- 
night to ensure inactivation of  v-ABL. They were then washed three 
times  to remove IL-3 before resuspension  at  a concentration of 
106/ml in DME (without r-glutamine; ICN Flow, Thames, UK), 
plus the additives indicated. After incubation for 18 h at 39 or 32~ 
apoptosis  was measured by acridine  orange staining to assess nu- 
clear  morphology, as previously described  (26). 
Results and Discussion 
Treatment with IL-3 or Activation  of v-ABL Stimulates Glu- 
cose Transport in IC.DP Cells.  IC.DP cells constitutively ex- 
press  the p160  v-abt tyrosine kinase  (Fig.  1 A),  which  is  ac- 
tive  at  32~  (permissive  temperature)  but  not  at  39~ 
(restrictive  temperature).  To  study  the effects  of this  PTK 
on glucose transport,  we assayed [3H]2-deoxyglucose uptake. 
This was potently inhibited by cytochalasin B  (CB; see also 
Fig.  3 A), indicating that it was catalyzed by a member(s) 
of the GLUT family of  passive sugar transporters (27).  Western 
blotting of IC.DP cell lysates using antibodies raised against 
the COOH  terminus of GLUT1 (24) showed that this trans- 
porter isoform was present in cells grown either at 32~  or 
at 39~  with (see Fig.  1 D) or without IL-3 (see Fig.  1 B). 
In contrast,  neither GLUT2, GLUT3, nor GLUT4 was de- 
Figure 1.  Effects of v-ABL activation and IL-3 on glucose transport 
in IC.DP cells. (-4) Phosphorylation of p160  ~abI was measured in IC.DP 
cells that had been maintained for 18 h at the restrictive (39~  or permis- 
sive (32~  temperatures for v-ABL activity, and then switched to the 
alternate temperature for the times shown. (B) Total cellular GLUT1 con- 
tent was measured in IC.DP cells that had been treated as in A. Results 
shown are from one representative experiment of three. ((2) Cells were 
incubated for a further period at 39~  or treated with purified recom- 
binant Ib3 (100 U/m1; a gift from Dr. J. Schreurs, DNAX, Palo Alto, 
CA) and/or switching the temperature to 32~  The uptake of 2-DOG 
was measured at the times indicated. The results shown are the mean _+ 
SEM of three experiments, and are expressed as a percentage of the uptake 
measured at 0 h (i.e., 2 h after washing to remove  Ib3 was initiated). The 
latter value was 2.36 nmol/min/106 cells. (D) Cells were incubated for 
a further 4 h after "0 h" at 39~  without IL-3  and then incubated with 
or without Ib3 at the temperatures indicated for a further period and the 
uptake of 2-DOG was measured at various times. Results (mean _+ SEM 
of three experiments) are expressed as a percentage of the uptake at 0 h 
(i.e., 6 h after washing to remove IL-3  was initiated). The latter value was 
0.80 nmol/min/106 cells. The inset shows the GLUT1 content of the cells 
at 39~  (at "6 h") with  or without  IL-3. 
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shown). 
When cells that had been grown overnight at 39~  in the 
presence of IL-3 were subsequently deprived of the growth 
factor and maintained at 39~  2-DOG uptake rates declined 
substantially relative to those for cells maintained in the pres- 
ence of IL-3 (Fig.  1 C). Readdition of IL-3 to cells deprived 
of the growth factor for 4 h caused a rapid return of uptake 
rates to the original levels, with a t0.s of about 1.5 h  (Fig. 
1  D).  However,  cells  incubated  at  32~  did  not  exhibit 
significant loss of transport  activity in the absence of IL-3 
(Fig.  1 C). This finding  suggests that  activation of v-ABL 
can partly  mimic  the effect of IL-3  on  glucose transport. 
Confirmation of this suggestion was provided by the obser- 
vation  that  switching  the  temperature  to  32~  for  cells 
deprived of IL-3 for 4 h at 39~  not only prevented any fur- 
ther decline of transport  activity over the subsequent 4 h, 
but in fact increased uptake rates by '~50% over this period 
(Fig.  1 D). 
To further characterize the transport activation induced by 
activation of the kinase, initial rates of sugar uptake were mea- 
sured over a range of 2-DOG concentrations.  Estimates of 
the Vm~, and Km were obtained using nonlinear curve fitting 
of the data (Enzfirter; Elsevier-Biosoft, Cambridge, UK; data 
not shown). A comparison was made of cells maintained at 
39~  for 6 h in the absence of IL-3 with cells maintained 
under these conditions for 4 h and then switched to 32~ 
for  2  h.  The  results  indicated  that  activation  of v-ABL 
significantly increased the Vm,x for transport,  from 1.52  + 
0.09 to 2.48  +  0.15 nmol/min/106  cells (mean  +  SEM, n 
=  3, p <0.01). Also, there was a decrease on the Km, which 
was 4.71  +  0.28 mM for the cells maintained at 39~  com- 
pared with 2.78  _+ 0.30 mM (mean  +  SEM, n =  3,p <0.01) 
for the cells  switched  to 32~ 
IL-3 treatment or v-ABL Activation Alters Subcellular Distri- 
bution  of the  GLUT1  Glucose  Transporter in  IC.DP  Cells. 
Chronic stimulation of glucose uptake by mammalian cells 
in response to serum, IL-1, or oncogenes such as the v-SRC 
PTK that is related to v-ABL, is mediated by an increase in 
the total cellular content of glucose transporters (28). In con- 
trast, the acute increase in sugar transport seen in many cell 
types after exposure to serum,  stress,  or insulin  appears to 
result  primarily  from translocation  of the  GLUT1  and/or 
GLUT4 transporter isoforms from an intracellular compart- 
ment to the plasma membrane (27-30). To ascertain the origin 
of the increase in transport  Vm,x induced in IC.DP cells by 
activation of v-ABL, quantitative Western blotting of GLUT1 
was performed as previously described (23).  In no case did 
we observe changes in the GLUT1  content  of the cells  as 
a consequence of switching  temperature from 39 to 32~ 
or from 32 to 39~  (see Fig. 1 B), indicating that the action 
of v-ABL on glucose transport  is not mediated by changes 
in the total cellular content of transporters. Furthermore, con- 
focal immunofluorescence microscopy showed not only that 
IC.DP cells contain a cytoplasmic, vesicular pool of GLUT1, 
but also that when IL-3-deprived cells were switched from 
39 to 32~  or IL-3 was added, there was a significant in- 
crease in the cell surface staining  of GLUT1  (Fig.  2).  This 
919  Kan et al. 
finding suggests that the effects both of IL-3 and of v-ABL 
activation on transport are at least in part mediated by trans- 
porter translocation from an intracellular pool to the cell sur- 
face, although v-ABL also appears to increase the apparent 
affinity of the transporter for substrate. Any role of change 
in the total GLUT1 levels present in these cells is excluded 
by the results of quantitative Western blotting experiments 
(see Fig. 1, B and D). In addition, the presence of the protein 
synthesis inhibitor  cydoheximide (up  to  100 ~M)  had no 
significant  effect on the changes in transport activity brought 
about by activation  of v-ABL or  addition  of IL-3  to  IL- 
3-deprived cells (data not shown). Furthermore the kinetics 
of the transport stimulation (t$/2 -~ 1-2 h) resemble those for 
stress- and serum-induced GLUT1 translocation in other cell 
types that,  similarly,  are independent  of protein  synthesis 
(29, 30). 
Inhibition of Glucose Transport  Induces Apoptosis in IC.DP Cells, 
an Effect That Can Be Reversed by Provision of  A lternative Energy 
Sources.  The observations described above suggested that sup- 
pression of apoptosis upon activation of v-ABL might be medi- 
ated partly via its effect upon sugar uptake by the IC.DP 
cells. To investigate this hypothesis further, we examined the 
effect of the potent inhibitor  of glucose transport,  CB. At 
a concentration of 10/~M (which can be calculated to reduce 
the rate of glucose transport by 17-fold at the concentration 
of extracellular glucose used in these experiments), this com- 
pound caused a ~>fourfold increase  in the rate of apoptosis 
of IL-3-deprived cells in which v-ABL had been activated 
by incubation at 32~  (Fig. 3, B and C). The effect of CB 
on apoptosis was dose dependent,  a twofold increase being 
observed at concentrations  (0.1-0.5  #M)  equivalent  to the 
Ki for inhibition  of GLUTl-mediated  transport  (Fig.  3 B) 
(28). For cells incubated at 39~  where the rate of apoptosis 
was already elevated as a result of inactivation of v-ABL, ad- 
dition of CB increased  apoptosis rates  still  further  (Fig.  3 
C).  The  involvement  of transport  inhibition  rather  than 
cytoskeletal disruption  in this phenomenon was confirmed 
by comparing the effect of dihydrocytochalasin B (DCB) with 
CB. DCB is a less potent inhibitor  of transport  (See Fig. 3 
A), but resembles CB in binding  tightly (Ka ~  10 nM) to 
micro filaments (31).  Although DCB did increase apoptosis 
rates to some extent,  its effect was much smaller than that 
of CB at all concentrations  tested (Fig.  3 B). The mode of 
cell death induced by CB was confirmed to be apoptosis using 
flow cytometric analysis  (data not  shown)  (32). 
Additional support for the hypothesis that deprivation of 
glucose, a major energy source for hemopoietic cells,  plays 
a part in the induction of apoptosis by CB or by IL-3 depri- 
vation, was provided in several ways. First, it was found that 
the effect of CB on the rate of apoptosis could be partly reversed 
by the provision of r-glutamine  or pyruvate as alternative 
energy  sources  (Fig.  3  C).  These  additives,  in  particular 
L-glutamine, also significantly suppressed the apoptosis pro- 
duced by incubation of IL-3-deprived IC.DP cells at 39~ 
(Fig.  3 C). Second, we found that  another competitive in- 
hibitor of transport, the membrane-impermeant disaccharide 
maltose (28), could also induce apoptosis. Its ICs0 for inhi- 









































































































































































































































































































































































































































































 Figure  3.  The effect of glucose transport  inhibition and of alternative energy sources on apoptosis in IC.DP cells. (A) The effect of CB, DCB 
and maltose (M) on 2-DOG uptake by IC.DP cells grown at 32~  was assessed by adding the compounds as indicated immediately before assay of 
transport.  Results (mean  _+  SEM, n  =  3) are expressed as a percentage of the uptake seen in the absence of any additive (NA),  which  was 2.18 
nmol/min/106 cells. (B) Dose-response curves for the effect of CB and DCB on the rate of apoptosis in IC.DP cells grown at 32~  (mean  _+ SEM, 
n  =  3). (C) The effect of 2 mM t-glutamine  (G) or 10 mM pyruvate (P) on the rate of CB (10/~M) induced apoptosis. Results (mean  _+  SEM, 
n  =  3) are expressed as a percentage of the number of apoptotic cells per 100 viable cells seen at 39~  without any additive (NA). Ethanol (EtOH) 
was used as the carrier for CB and DCB. (D) The effect of 2 mM L-glutamine (G) or 10 mM pyruvate (P) on the rate of 20 mM maltose-induced 
apoptosis in IC.DP cells. Results (mean _+ SEM, n  =  3) are expressed as a percentage of the number of apoptotic ceUs/100 viable cells seen at 39~ 
without any additive (NA). (E) The effect of extraceltular glucose concentration on the rate of apoptosis in IC.DP cells. Cells were treated as in (C) 
and (/9) except that incubations were in PBS, pH 7.3, containing 0.1% (wt/vol)  BSA and the concentration of glucose indicated. Results (mean  _+ 
SEM, n  =  3) are expressed as a percentage of the number of apoptotic cells present after incubation in 0.1 mM glucose (GC) at 39~  which was 
95% of  the number of  viable cells. (F) The effect of  glucose starvation on expression  of  GLUT1 in IC.DP cells. Results shown are from one representative 
experiment of three. 
10  mM  (Fig.  3  A).  Addition  of 20  mM  maltose  (but  not 
20 mM sucrose, which  does not inhibit  transport,  data not 
shown)  inhibited  the suppression  of apoptosis produced by 
activation of v-ABL in IL-3-deprived IC.DP cells,  thereby 
increasing the rate of apoptosis to a level similar to that seen 
at 39~  (Fig.  3  D).  Once  again,  provision  of t-glutamine 
or pyruvate as alternative  energy source partially overcame 
the effect of maltose (Fig. 3 D). Finally, we found that directly 
decreasing the glucose supply to the cells,  by lowering  the 
sugar concentration  in the medium,  also increased  the rate 
of apoptosis in IL-3-deprived cells, both at 32 and 39~  (Fig. 
3  E).  Much  more  severe restriction  of glucose  supply was 
required  to induce  apoptosis in  such  experiments  than had 
been  expected  from  the  effects of maltose or  CB  reported 
above. However, the relatively small effect on apoptosis ob- 
served in  a  decrease between  25  and  2.5  mM  glucose  may 
be due  to the fact that we observed an increase in GLUT1 
expression  upon  glucose  deprivation  (see Fig.  3  F),  as  has 
previously been described elsewhere (33-37), which will pre- 
sumably lead  to greater  glucose  uptake. 
Taken together, our results indicate that the supply of energy 
in the form of glucose or other substances directly influences 
the  rate  of apoptosis  in  IC.DP  cells.  We  suggest  that  one 
of the criteria that hemopoietic cells need to meet in order 
to avoid apoptosis is to maintain a favorable energy balance. 
Should the latter fall below a certain crucial point, the preex- 
isting program for apoptosis will be executed. Oncogene and 
cytokine stimulation of glucose transport therefore represents 
a regulatory  control  point  in  the  suppression  of apoptosis. 
We do not  suggest  that  maintenance  of a favorable energy 
balance is the sole regulatory point  governing apoptosis in 
hemopoietic cells; cytokines and other proteins such as bcl-2 
are likely to elicit a pleiotropic set of effects to suppress apop- 
tosis.  However,  our data  do  indicate  one  aspect  of cellular 
metabolism that may be disregulated in multistage leukemo- 
genesis. 
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